
ECMO in Sickle Cell Disease: Outcomes and Evidence Gaps
A systematic review examines ECMO in sickle cell disease, highlighting uncertain mortality estimates, complication reporting gaps, and implications for perfusion teams.
Explore articles, research, and perspectives from the International Perfusion Association.

A systematic review examines ECMO in sickle cell disease, highlighting uncertain mortality estimates, complication reporting gaps, and implications for perfusion teams.

A review of vasoactive support during VA-ECMO examines ventricular loading, mixed shock, drug selection, and the limits of current outcome evidence.

A narrative review examines acute kidney injury after cardiac surgery, connecting bypass-related injury, early biomarkers, prevention bundles, and long-term renal recovery.

A focused review examines cardioplegia in aortic stenosis, including ventricular hypertrophy, solution choice, temperature, delivery, dosing, and redosing.

A meta-analysis of randomized trials found perioperative albumin unlikely to reduce acute kidney injury after on-pump cardiac surgery. Explore the results and their relevance

A meta-analysis of 851 patients links external aortic wrapping with shorter bypass and cross-clamp times, but does not establish equivalent safety or long-term durability.

A regional systematic review examines mortality, serious bleeding, and duration of ECMO support in adults with COVID-19, with very low-certainty evidence limiting comparisons across

A systematic review finds substantial bloodstream-infection burden during adult ECMO, but wide variation and very low-certainty evidence limit conclusions about prevalence and infection-attributable mortality.

A JACC review explores AI in valve screening, imaging, procedural planning, and risk prediction, while emphasizing validation, human oversight, and the gap between technical

A bibliometric review maps 4,565 studies of ischemia–reperfusion injury in cardiac surgery and transplantation, identifying cardioplegia’s large literature and emerging preclinical themes without establishing

A meta-analysis of three randomized trials involving 407 adults found no significant differences between bivalirudin and heparin in major clinical or transfusion outcomes. Small

A review of bloodless medicine connects anemia treatment, perfusion blood conservation, and individualized consent, with an update to current religious guidance.
This site is protected by reCAPTCHA.
IPA COMMUNITY POLL
Loading poll…